Total Visits

Views
DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer75

Select a period of time:

Views

Views
June 20253
July 202529
August 20252
September 20253
October 20251
November 20252
December 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States15
Brazil11
United Kingdom2
Turkey2
Austria2
Argentina1
Dominican Republic1
Hong Kong1
Jamaica1
Morocco1
 

Top cities views

Views
Dallas3
Istanbul2
Arapongas1
Bagé1
Belvidere1
Caraguatatuba1
Casablanca1
Cheltenham1
Cleveland1
Dajabón1